
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

21,982 Listeners

43,977 Listeners

32,107 Listeners

38,487 Listeners

6,785 Listeners

43,730 Listeners

27,206 Listeners

2,859 Listeners

9,193 Listeners

466 Listeners

722 Listeners

924 Listeners

6,381 Listeners

931 Listeners

32 Listeners